ArticleAllergy, asthma & immunology research2022

Interleukin-17 Can Be the Target of Novel Treatment Strategies for Particulate Matter-Induced Allergic Diseases.

Byeong-Gon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.